Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ahn-Gook Pharmaceutical Co Ltd
Total Current Assets
Ahn-Gook Pharmaceutical Co Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
Total Current Assets
₩136.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
|
Yuhan Corp
KRX:000100
|
Total Current Assets
₩1.5T
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Current Assets
₩683.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Current Assets
₩893.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Current Assets
₩241.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Current Assets
₩83.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Ahn-Gook Pharmaceutical Co Ltd
Glance View
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.
See Also
What is Ahn-Gook Pharmaceutical Co Ltd's Total Current Assets?
Total Current Assets
136.8B
KRW
Based on the financial report for Dec 31, 2025, Ahn-Gook Pharmaceutical Co Ltd's Total Current Assets amounts to 136.8B KRW.
What is Ahn-Gook Pharmaceutical Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
0%
Over the last year, the Total Current Assets growth was 1%. The average annual Total Current Assets growth rates for Ahn-Gook Pharmaceutical Co Ltd have been 4% over the past three years , 4% over the past five years .
